HIV Infections: all 4,342 studies

Page 14 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.

• Tele-Harm ReductionCompletedNCT05208697Not applicable
• A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive IndividualsCompletedNCT05208125Phase 1
• Sexual Needs of Adolescents Living With HIV Since ChildhoodCompletedNCT05206123
• Study to Evaluate Pharmacokinetic and Safety of Albuvirtide Between Intravenous Drip and Intravenous InjectionCompletedNCT05206019Phase 1
• Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy VolunteersCompletedNCT05204121Phase 1
• Situational Analysis of HIV-related Disability in the Context of Ivory CoastCompletedNCT05199831
• A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected ChildrenCompletedNCT05197075Phase 1
• Type 1 Hybrid Trial of Our Plan - a Brief, Couples-based HIV/STI Prevention InterventionCompletedNCT05193942Not applicable
• Trauma Intervention to Optimize PrEP Among Women Who Inject DrugsActive, not recruitingNCT05192434Not applicable
• The Impact Evaluation of the COVID-19 Prevention on Risk Factors of HIV and Sexually Transmitted ComorbidityStatus unknownNCT05188456
• ResIlience-based Stigma REdUction Program ("Rise-up")Active, not recruitingNCT05174936Not applicable
• Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral TherapyStatus unknownNCT05168137Phase 4
• Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in IndiaCompletedNCT05165810Not applicable
• Virtual PrEP: Rendering PrEP Delivery More EfficientTerminatedNCT05159531Phase 4
• Neurofeedback Training (NFT) on Sleep Quality and Cognitive Function Performance Among HIV-infected PersonsCompletedNCT05155787Not applicable
• Long-Acting Treatment in Adolescents (LATA)Status unknownNCT05154747Phase 3
• Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIVCompletedNCT05154513
• Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigmaCompletedNCT05149001
• A Drug-drug Interaction Study of SHR2150 on Healthy Chinese VolunteersStatus unknownNCT05141422Phase 1
• Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American WomenCompletedNCT05139069Not applicable
• Using Mobile Technology to Prevent HIV and Related Youth Health ProblemsSuspendedNCT05130151Not applicable
• A Study of Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)WithdrawnNCT05130086Phase 2
• Functional Cure Study of Anti-PD-L1 Antibody ASC22 in Combination With Chidamide in HIV-infected Patients With Antiviral SuppressionStatus unknownNCT05129189Phase 2
• Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention CenterCompletedNCT05127187Not applicable
• DENTAL CARE OF PATIENTS LIVING WITH HIVCompletedNCT05123547
• Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 InfectionActive, not recruitingNCT05122754Phase 4
• Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)WithdrawnNCT05115838Phase 2
• Making PrEP Smart: An HIV Testing and PrEP Electronic Support Tool ("SmartPrEP" App) for Women on PrEPCompletedNCT05111119Not applicable
• Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV InfectedStatus unknownNCT05105295Phase 4
• Active Hexose Correlated Compound in Tuberculosis-HIV (Human Immunodeficiency Virus) InfectionCompletedNCT05100758Not applicable
• Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for ChildrenCompletedNCT05085717
• Pathogen Detection in HIV-infected Children With Non-malarial Febrile Illnesses Using Metagenomic SequencingActive, not recruitingNCT05085158
• Life Experience of People Aged 60 and Over Living with HIVCompletedNCT05083273
• Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATIWithdrawnNCT05079451Phase 1
• Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto RicoActive, not recruitingNCT05074264Not applicable
• Optimised Electronic Patient Records to Improve Clinical Monitoring of HIV-positive Patients in Rural South AfricaStatus unknownNCT05071573Not applicable
• Evaluation of HIV-1 Recent Infection Testing in RwandaCompletedNCT05063487
• Mobile Phone Text Messaging Plus Motivational Interviewing: Effects on Breastfeeding, Child Health OutcomesActive, not recruitingNCT05063240Not applicable
• Safety and Immune Response of COVID-19 Vaccination in Patients With HIV InfectionStatus unknownNCT05043129
• Supporting Sustained HIV Treatment Adherence After InitiationCompletedNCT05040841Not applicable
• Food as Medicine for HIV and DiabetesActive, not recruitingNCT05026723Not applicable
• HIV Resilience Qualitative Study Hong KongCompletedNCT05021653
• Behavioural Text Messages to Improve Retention in Care in South AfricaCompletedNCT05010291Not applicable
• Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIVStatus unknownNCT05006170Phase 2
• Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)CompletedNCT05002907
• Expanding the Potential of Couples HIV Testing: Adjunct Modules to Reduce Drug Use Among Vulnerable Male CouplesCompletedNCT05000866Not applicable
• Supplementation Trial of KOKO Plus Among HIV Exposed Children in AccraStatus unknownNCT04995874Not applicable
• Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral TherapyCompletedNCT04985760Phase 1
• Efficacy, Tolerability and Acceptability of Biktarvy by TPLWHTerminatedNCT04944654Phase 4
• Prevalence and Risk Factors of HIV Infections in Transgender and Non-binary People in Flanders and Brussels (Belgium)CompletedNCT04930614
• Therapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerActive, not recruitingNCT04929028Phase 2
• Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected AdultsCompletedNCT04927585Phase 1
• In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected HumansCompletedNCT04920539Phase 1
• Study to Determine Therapeutic Massage Dosing to Improve Quality of Life in Hospitalized Patients Receiving Palliative CareCompletedNCT04916223Not applicable
• Enhanced Adherence Counselling, Pre-Post StudyCompletedNCT04915469Not applicable
• Developing a Chatbot to Promote HIV TestingCompletedNCT04910984
• Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIVActive, not recruitingNCT04910711Phase 4
• Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected IndividualsCompletedNCT04904406Phase 4
• Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir DisproxilStatus unknownNCT04903847Phase 4
• Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy (the PEDAL Study)Status unknownNCT04901728
• Immunogenicity of COVID-19 Vaccination in PLWHStatus unknownNCT04894448
• Neuropathy Walks (Cross-sectional)CompletedNCT04889521
• Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a WeekStatus unknownNCT04867083Phase 3
• Contingency Management for Cannabis Use for Persons With HIVCompletedNCT04866004Not applicable
• Cabenuva Injection Tracking in CHORUSCompletedNCT04863261Not applicable
• Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in BotswanaCompletedNCT04862975
• HIV Prevention and PrEP Intervention for SGM Adolescents and Parents: "Hey, Friend"WithdrawnNCT04846946Not applicable
• Aspects of Vulnerability of People Living with HIV in the Alpine Arc RegionCompletedNCT04846595Not applicable
• Acceptability, Feasibility and Preliminary Impact of OurPlan, an mHealth HIV Prevention Intervention for Male CouplesCompletedNCT04836091Not applicable
• Cross-disciplinary HIV Integrated Mental Health Support InterventionActive, not recruitingNCT04833829Not applicable
• Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)Active, not recruitingNCT04826562Phase 4
• Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 InfectionStatus unknownNCT04819347Phase 2
• Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole BloodCompletedNCT04810559Not applicable
• HIV Infection And Evolvement of Atherosclerotic PlaqueStatus unknownNCT04810364
• DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant WomenCompletedNCT04808973Phase 3
• Gut Microbiota, PGx and INSTIs ResponseCompletedNCT04805944
• Acceptability, Feasibility and Impact of Oral HIV Self-testing for Partner Testing Among Kenyan Adolescent Girls Aged 15-19 Years: A Randomized Controlled TrialCompletedNCT04805112Not applicable
• Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)CompletedNCT04799353Phase 1
• MOVIDA 1 Ter - Evaluation of the Cobas® Plasma Separation Card in the Field in VietnamCompletedNCT04794725Not applicable
• Patient-Reported Outcomes HIV BItherapyStatus unknownNCT04788784
• PrEP Among MSM and TG in MyanmarCompletedNCT04781426
• Bidirectional, Upbeat Communication and Differentiated, Distanced Care for Young PeopleCompletedNCT04781400Not applicable
• Mitigating Sexual Stigma Within Healthcare Interactions Improve Engagement of MSM in HIV PreventionCompletedNCT04779736Not applicable
• A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy PreventionActive, not recruitingNCT04778527Not applicable
• A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy PreventionCompletedNCT04778514Not applicable
• Impact of Containment and the Current Epidemic on the Sexual Risk-taking of People Using PrEP to Prevent HIV Infection.Status unknownNCT04772326
• HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyStatus unknownNCT04768517
• Community-Based Model for Delivery of Antiretroviral Therapy in CambodiaCompletedNCT04766710Not applicable
• Cardiometabolic Health of Children Exposed to Anti-retroviral Therapy (ART) in UteroStatus unknownNCT04763668
• Low-dose Fostemsavir Extended Release Relative Bioavailability StudyCompletedNCT04757974Phase 1
• Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell TransplantationWithdrawnNCT04720742Phase 2
• Same-day Antiretroviral Therapy With BIC/F/TAFStatus unknownNCT04712058Not applicable
• Optimizing Malaria Treatment for HIV-Malaria Co-infected IndividualsStatus unknownNCT04708496Phase 4
• Electronic Capture of Adherence Barriers for HIV CareStatus unknownNCT04702412Not applicable
• PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in KenyaCompletedNCT04666792Phase 4
• Resilience-based Psychosocial Intervention Among Children Affected by HIV/AIDSCompletedNCT04653441Not applicable
• Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'CompletedNCT04653194Phase 3
• CAR-T Cells for HIV InfectionActive, not recruitingNCT04648046Phase 1/2
• Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE)Active, not recruitingNCT04641013
• HIV Drug Resistance Pattern Due to Migration in PolandStatus unknownNCT04636736

← HIV Infections overview